DEA schedule

Is Prolensa a controlled substance?

Prolensa contains bromfenac. Federal schedule from the FDA NDC directory, checked against the DEA controlled substances list.

Source: FDA NDC Directory file dated 2026-10-22. Publisher page

No. Prolensa (bromfenac) is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and bromfenac is not on the DEA controlled substances list.

Run it in Rivvi

Which 2027 plans near you dropped or restricted Prolensa?

Tier changes and new prior auth, step therapy or quantity limits, plan by plan.

Free to start. Opens Rivvi, the AI workspace for healthcare teams.

Schedule check

Schedule sources for Prolensa
Source	What it lists
FDA NDC directory	1 prescription listings from 1 labelers, none with a DEA schedule
DEA controlled substances list	bromfenac is not on the list

Prolensa NDC listings

NDC listings for Prolensa
NDC	Product	Form	Strength	Labeler	DEA schedule
24208-602	Prolensa	solution/ drops	.7 mg/mL	Bausch & Lomb Incorporated	None

Questions

Is Prolensa a controlled substance?

No. Prolensa (bromfenac) is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and bromfenac is not on the DEA controlled substances list.

Is Prolensa a narcotic?

No. Prolensa (bromfenac) is not on the DEA controlled substances list, so the DEA does not classify it as a narcotic. Its FDA established pharmacologic class is Nonsteroidal Anti-inflammatory Drug.

Does this page cover state schedules?

No. This page reports the federal schedule only. Some states schedule drugs on their own; check your state board of pharmacy.

Is Prolensa a controlled substance?

Which 2027 plans near you dropped or restricted Prolensa?

Schedule check

Prolensa NDC listings

Questions

More on Prolensa

Try it on your own data today.